Article

Identification of potential biomarkers and inhibitors for SARS-CoV-2 infection

2020-09-18

Abstract excerpt

The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has overwhelmed many health systems globally. Here, we aim to identify biological markers and associated biological processes of COVID-19 using a bioinformatics approach to elucidate their potential pathogenesis. The gene expression profile of the GSE152418 dataset was originally produced by using the high-throughput Illum...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e8d2ac54-f1f7-55ec-815f-607803f38b4d
DOI: 10.1101/2020.09.15.20195487

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification of potential biomarkers and inhibitors for SARS-CoV-2 infectionDOI 10.1101/2020.09.15.20195487Read

Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: Insights from machine learning and bioinformatics approachesSemantic proximity Read

Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: insights from machine learning and bioinformatics approachesSemantic proximity Read

The transcriptomic profiling of COVID-19 compared to SARS, MERS, Ebola, and H1N1Semantic proximity Read

Cancer related-genes enriched in peripheral blood mononuclear cells (PBMCs) of COVID-19 patients. a bioinformatics studySemantic proximity Read

Bioinformatics analysis of expression profiling by high throughput sequencing for identification of potential key genes among SARS-CoV-2/COVID 19Semantic proximity Read

Transcriptomic Signatures and Repurposing Drugs for COVID-19 Patients: Findings of Bioinformatics AnalysesSemantic proximity Read

SARS-CoV-2 Infections - Gene Expression Omnibus (GEO) Data Mining, Pathway Enrichment Analysis, and Prediction of Repurposable Drugs/CompoundsSemantic proximity Read

Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in severe acute respiratory syndrome corona virus 2 infection/COVID 19Semantic proximity Read

Identification of key genes in SARS-CoV-2 patients on bioinformatics analysisSemantic proximity Read

Transcriptome and SARS-CoV-2 biological network directed analysis for better therapeutic developmentSemantic proximity Read

Secondary analysis of transcriptomes of SARS-CoV-2 infection models to characterize COVID-19Semantic proximity Read

Molecular signatures in the progression of COVID-19 severitySemantic proximity Read